Machine Learning For Drug Discovery Articles Big Data

AstraZeneca's announcement today that they have joined forces with Human Longevity, a US sequencing and machine learning company, to sequence 2 million genomes is therefore not a surprise as such, but it does represent a step up in terms of the scale of such projects. AstraZeneca will be able to use Human Longevity's database of 1 million genomic and heath records alongside 500,000 DNA samples from their own clinical trials. The creation of this new database is likely to take as long as a decade, but the project will also include sequences from samples donated in the past 15 years.